Point72 Asset Management, L.P.

Q4 2022 13F-HR/A Detailed Holdings

Location
Stamford, CT
Holdings as of
12/31/2022
Date filed
5/15/2023
Form type
13F-HR/A - RESTATEMENT
Num holdings
1,474
Total value ($000)
$29,421,581
Net value change ($000)
+4,384,746 (17.5%)
New positions
396
Sold out positions
325
Turnover %
37.3%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CRM 443,612 NEW
AVGO 315,383 234.9%
META 297,453 113.5%
UBER 241,162 17300.0%
AMZN 216,492 104.2%
NFLX 211,900 NEW
TDG 177,627 1165.6%
NTAP 172,966 NEW
SU 166,982 NEW
FIS 158,630 63.0%
Top Reduces (Value $000, Stocks/ETFs)
TMUS -256,441 -83.7%
PANW -231,590 -100.0%
WDAY -161,644 -100.0%
AZN -159,494 -60.4%
ROST -145,364 -99.0%
JNP -136,950 -83.8%
XLE -133,449 -87.9%
EOG -131,265 -100.0%
Horizon Therapeutics Public Ltd Co -129,622 -100.0%
BILL -129,355 -91.2%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,948,530 (10.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None